Skip Nav Destination
Issues
Pathophysiology of Haemostasis and Thrombosis 2003/2004, Vol. 33, No. 5-6
Special Section
Title Page / Table of Contents
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 233–236.
https://doi.org/10.1159/000083807
Preface
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 237–238.
https://doi.org/10.1159/000083808
Plenary Lectures
Angiogenesis: A link to Thrombosis in Athero-thrombotic Disease
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 241–248.
https://doi.org/10.1159/000083809
Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 249–255.
https://doi.org/10.1159/000083810
Assessment of Endothelial Dysfunction: Focus on Atherothrombotic Disease
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 256–261.
https://doi.org/10.1159/000083811
Different Locations of Atherosclerosis – Different Risk Factors, Different Therapies?
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 262–266.
https://doi.org/10.1159/000083812
State-of-the-art Lectures
Thromboembolic Diseases in Neonates and Children
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 269–274.
https://doi.org/10.1159/000083813
Metalloproteinases in Development and Progression of Vascular Disease
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 275–281.
https://doi.org/10.1159/000083814
Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 282–289.
https://doi.org/10.1159/000083815
Adipose Tissue and Atherothrombosis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 290–297.
https://doi.org/10.1159/000083816
Asymptomatic Carotid Stenosis: Natural History and Therapeutic Implications
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 298–301.
https://doi.org/10.1159/000083817
Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 302–308.
https://doi.org/10.1159/000083818
Focus on: Venous Thromboembolism
Controversial Issues in the Diagnosis of Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 311–313.
https://doi.org/10.1159/000083819
Extended Versus Rapid Analysis of the Leg Vein System: a Multicenter Ultrasound Study (The ERASMUS Study) – An Interim Analysis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 314–318.
https://doi.org/10.1159/000083820
The Role of Helical CT in the Diagnosis of Pulmonary Embolism
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 319–326.
https://doi.org/10.1159/000083821
D-Dimer Testing in Pregnancy
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 327–329.
https://doi.org/10.1159/000083822
Management of Patients with Acute Venous Thromboembolism: Findings from the RIETE Registry
Manuel Monreal; Carmen Suárez; José A.G. Fajardo; Raquel Barba; Fernando Uresandi; Reina Valle; Pilar Rondón
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 330–334.
https://doi.org/10.1159/000083823
Focus on: Homocysteine
Gene-Gene and Gene-Environment Interactions in Mild Hyperhomocysteinemia
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 337–341.
https://doi.org/10.1159/000083824
Homocysteine, Vitamin B6 and the Risk of Recurrent Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 342–344.
https://doi.org/10.1159/000083825
Is Hyperhomocysteinemia an Important Risk Factor of Cardiovascular Disease?
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 345–347.
https://doi.org/10.1159/000083826
Focus on: Prevention of Venous Thromboembolism
Risk Factors of Recurrent Venous Thromboembolism: The Role of Residual Vein Thrombosis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 351–353.
https://doi.org/10.1159/000083827
Duration of Anticoagulant Treatment after VenousThromboembolism
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 354–357.
https://doi.org/10.1159/000083828
Assessment of the Risk and the Prophylaxis of Venous Thromboembolism in Surgical Patients
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 358–361.
https://doi.org/10.1159/000083829
Assessment of the Risk and Prophylactic Treatment of Venous Thromboembolism in the Elderly
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 362–365.
https://doi.org/10.1159/000083830
Computer Assisted Anticoagulant Therapy
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 366–372.
https://doi.org/10.1159/000083831
Focus on: Thrombin Activatable Fibrinolysis Inhibitor (RAFI)
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) at the Interface between Coagulation and Fibrinolysis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 375–381.
https://doi.org/10.1159/000083832
Plasma Thrombin-Activatable Fibrinolytic Inhibitor (TAFI) among Healthy Subjects and Patients with Vascular Diseases: A Validation Study
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 382–386.
https://doi.org/10.1159/000083833
Focus on: Cancer and Venous Thromboembolism
Biological and Clinical Aspects of Anticancer Effects of Antithrombotics
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 389–392.
https://doi.org/10.1159/000083834
Focus on: Management of Thrombophilia
Elevated Clotting Factor Levels and Venous Thrombosis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 395–400.
https://doi.org/10.1159/000083835
Management of Thrombophilia: Who to Screen?
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 401–404.
https://doi.org/10.1159/000083836
Focus on: Thrombocytopenia
New Developments in Diagnosis and Treatment of Heparin-induced Thrombocytopenia
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 407–412.
https://doi.org/10.1159/000083837
Trombocytopenia: One of the Markers of Disseminated Intravascular Coagulation
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 413–416.
https://doi.org/10.1159/000083838
The von Willebrand Factor-Cleaving Protease (ADAMTS-13) and the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP)
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 417–421.
https://doi.org/10.1159/000083839
Focus on: Fibrinolytic System and Thrombosis
The Fibrinolytic System and Thrombotic Tendency
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 425–429.
https://doi.org/10.1159/000083840
Fibrin Stabilization (Factor XIII), Fibrin Structure and Thrombosis
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 430–437.
https://doi.org/10.1159/000083841
New Aspects in Thrombotic Research: Complement Induced Switch in Mast Cells from a Profibrinolytic to a Prothrombotic Phenotype
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 438–441.
https://doi.org/10.1159/000083842
Focus on: Virchow’s Triad
How a Damaged Blood Vessel Wall Contibutes to Thrombosis and Hypertenasion
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 445–448.
https://doi.org/10.1159/000083843
Virchow’s Triad Revisited: Blood Constituents
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 449–454.
https://doi.org/10.1159/000083844
Virchow’s Triad Revisited: Abnormal Flow
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 455–457.
https://doi.org/10.1159/000083845
Focus on: Dietary Interventions
Mediterranean Diet and Health: Is all the Secret in Olive Oil?
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 461–465.
https://doi.org/10.1159/000083846
The Mediterranean Lecture: Wine and Thrombosis – From Epidemiology to Physiology and Back
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 466–471.
https://doi.org/10.1159/000083847
Haemostatic Cardiovascular Risk Factors: Differential Effects of Red Wine and Diet on Healthy Young
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 472–478.
https://doi.org/10.1159/000083848
Focus on: New Antithrombotic Strategies
Platelet Proteomics: Identification of Potential Therapeutic Targets
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 481–486.
https://doi.org/10.1159/000083849
Peptidomimetic Thrombin Inhibitors
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 487–491.
https://doi.org/10.1159/000083850
Focus on: Circulating Endothelial Cells
Circulating Endothelial Cells: Realities and Promises in Vascular Disorders
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 495–499.
https://doi.org/10.1159/000083851
Circulating Endothelial Cells in Vasculitis and Transplantation
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 500–502.
https://doi.org/10.1159/000083852
Strategies to Investigate Circulating Endothelial Cells in Cancer
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 503–506.
https://doi.org/10.1159/000083853
Further Section
Contents Vol. 33
Pathophysiology of Haemostasis and Thrombosis (2003) 33 (5-6): 512–513.
https://doi.org/10.1159/000083854
